Allovir, Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Allovir, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Allovir, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$7.77M, a 83.6% increase year-over-year.
  • Allovir, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$149M, a 14.1% increase year-over-year.
  • Allovir, Inc. annual Operating Income (Loss) for 2023 was -$200M, a 16.8% decline from 2022.
  • Allovir, Inc. annual Operating Income (Loss) for 2022 was -$171M, a 0.82% decline from 2021.
  • Allovir, Inc. annual Operating Income (Loss) for 2021 was -$170M, a 138% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$200M -$28.7M -16.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-15
2022 -$171M -$1.38M -0.82% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
2021 -$170M -$98.5M -138% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-15
2020 -$71.3M -$44.6M -167% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-10
2019 -$26.7M Jan 1, 2019 Dec 31, 2019 10-K 2021-02-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.